Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

If you liked this article you might like

Opioid Litigants Get Boost From Senate Report

Opioid Litigants Get Boost From Senate Report

Skyworks Solutions Is 1 of 5 Big Stocks Ready to Abruptly Change Direction

Skyworks Solutions Is 1 of 5 Big Stocks Ready to Abruptly Change Direction

These Are the Biggest Winners and Losers in Activist Investing This Year

These Are the Biggest Winners and Losers in Activist Investing This Year

Opioid Makers Buffeted by Trump's Declaration of Addiction Crisis

Opioid Makers Buffeted by Trump's Declaration of Addiction Crisis

Biotech Movers: FibroGen Leaps on Results for Pulmonary Fibrosis Study

Biotech Movers: FibroGen Leaps on Results for Pulmonary Fibrosis Study